HomeOwner SearchCategory Search
Visit USCOClinical Pharmacology & Therapeutics [Published: 2018-10-31. Issue: vol. 104, no. 5, NOVEMBER 2018]
Serial Registration
Copyright Title
Clinical Pharmacology & Therapeutics [Published: 2018-10-31. Issue: vol. 104, no. 5, NOVEMBER 2018]
Status
Published
on 12 Nov 2018
Year of Creation
2018
Copyright Claimant
American Society for Clinical Pharmacology and Therapeutics
Registration Number
TX0008665002
on 12 Nov 2018Copyright Summary
The U.S. Copyright record (Registration Number: TX0008665002) dated 12 Nov 2018, pertains to an electronic file (eService) titled "Clinical Pharmacology & Therapeutics [Published: 2018-10-31. Issue: vol. 104, no. 5, NOVEMBER 2018]" created in 2018. The copyright holder is American Society for Clinical Pharmacology and Therapeutics, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to American Society for Clinical Pharmacology and Therapeutics.
Application Details
Registration Number
TX0008665002
Registration Date
11/12/2018
Year of Creation
2018
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
American Society for Clinical Pharmacology and Therapeutics
First Publication Nation
United States
ISSN
0009-9236
Notes
Copyright Local Holdings: vol. 104, no. 5, NOVEMBER 2018 Created 2018 Pub. 2018-10-31 Reg. 2018-11-15 TX0008665002 PGAW
Statements
Application Title Statement: Clinical Pharmacology & Therapeutics
Author Statement: American Society for Clinical Pharmacology and Therapeutics employer for hire Domicile: United States Citizenship: United States Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.